Advertisement

Dermatologic manifestations of hypopituitarism

      Abstract

      Hypopituitarism is characterized by diminished or absent secretion of one or more pituitary hormones. The clinical features of hypopituitarism vary depending on age, rapidity of onset, hormones involved, and degree of deficiency. Dermatologic signs of hypopituitarism may involve alterations in pigmentation, the epidermal and dermal skin structures, and the pilosebaceous unit. We describe the causes and presentation of hypopituitarism with an emphasis on its dermatologic manifestations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Melmed S.
        • Kleinberg D.
        Anterior pituitary.
        in: Larson P.R. Kronberg H.M. Melmed S. Polonsky K.S. Williams textbook of endocrinology. 10th ed. Elsevier Science, Philadelphia2003: 177-280
        • Toogood A.A.
        Endocrine consequences of brain irradiation.
        Growth Horm IGF Res. 2004; 14: S118-S124
        • Darzy K.H.
        • Shalet S.M.
        Radiation-induced growth hormone deficiency.
        Horm Res. 2003; 59: 1-11
        • Kelly D.F.
        • Gpnzalo I.T.
        • Cohan P.
        • et al.
        Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report.
        J Neurosurg. 2000; : 743-752
        • Aimaretti G.
        • Ambrosio M.R.
        • Di Somma C.
        • et al.
        Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury.
        Clin Endocrinol (Oxf). 2004; 61: 320-326
        • Aron D.C.
        • Findling J.W.
        • Tyrrell J.B.
        Hypothalamus and pituitary gland.
        in: Greenspan F.S. Gardner D.G. Basic and clinical endocrinology. 7th ed. Lange, New York2004: 106-175
        • Zouboulis C.C.
        Human skin: an independent peripheral endocrine organ.
        Horm Res. 2000; 54: 230-242
        • Grando S.A.
        Physiology of endocrine skin interrelations.
        J Am Acad Dermatol. 1993; 28: 981-992
        • Slominski A.
        • Wortsman J.
        Neuroendocrinology of the skin.
        Endocr Rev. 2000; 21: 457-487
        • Bonert-Herman V.
        • Melmed S.
        Growth hormone.
        in: Melmed S. Pituitary. 2nd ed. Blackwell, Malden2002: 79-118
        • Rosen M.
        • Cedars M.I.
        Female reproductive endocrinology and infertility.
        in: Greenspan F.S. Gardner D.G. Basic and clinical endocrinology. 7th ed. Lange, New York2004: 511-563
        • Bichet D.G.
        The posterior pituitary.
        in: Melmed S. Pituitary. 2nd ed. Blackwell, Malden2002: 279-314
        • Carlson H.E.
        The pituitary gland in pregnancy and the puerperium.
        in: Melmed S. Pituitary. 2nd ed. Blackwell, Malden2002: 633
        • Sheehan H.L.
        • Davis J.C.
        Post-partum hypopituitarism. Charles C. Thomas, Springfield1982: 222-229
        • Aboud C.F.
        Anterior pituitary failure.
        in: Melmed S. Pituitary. 2nd ed. Blackwell, Malden2002: 350-351
        • Cummings G.E.
        • Merriam G.R.
        Growth hormone therapy in adults.
        Annu Rev Med. 2003; 53: 513-533
        • Larson P.R.
        • Davies T.F.
        Hypothyroidism and thyroiditis.
        in: Larson P.R. Kronberg H.M. Mnelmed S. Polonsky K.S. Williams textbook of endocrinology. 10th ed. Elsevier Science, Philadelphia2003: 423-455
        • Jabbour S.A.
        • Miller J.L.
        Endocrinopathies and the skin.
        Int J Dermatol. 2000; 39: 88-99
        • Rosenberg R.M.
        • Isseroff R.R.
        • Ziboh V.A.
        • Huntley A.C.
        Abnormal lipogenesis in thyroid hormone–deficient epidermis.
        J Invest Dermatol. 1986; 86: 244-248
        • Leonhardt J.M.
        • Heymann W.R.
        Thyroid disease and the skin.
        Dermatol Clin. 2002; 20: 473-481
        • Randall V.A.
        • Hibberts N.A.
        • Thornton M.J.
        • et al.
        The hair follicle: a paradoxical androgen target organ.
        Horm Res. 2000; 54: 243-250
        • Feingold K.R.
        • Elias P.M.
        Endocrine-skin interactions. Cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders, and diabetes.
        J Am Acad Dermatol. 1987; 17: 921-940
        • Braunstein G.D.
        Androgen deficiency in women.
        in: Carr B.R. Blackwell R.E. Azziz R. Essential reproductive medicine. McGraw-Hill, New York2005: 683-702
        • Paus R.
        Does prolactin play a role in skin biology and pathology?.
        Med Hypotheses. 1991; 36: 33-42
        • Foitzik K.
        • Krause K.
        • Nixon A.J.
        • et al.
        Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle–dependent expression, and induce catagen.
        Am J Pathol. 2003; 162: 1611-1621
        • Blum I.
        • Leiba S.
        Increased hair loss as a side effect of bromocriptine treatment.
        N Engl J Med. 1980; 303: 1418
        • Thiboutot D.M.
        Clinical review 74: dermatological manifestations of endocrine disorders.
        J Clin Endocrinol Metab. 1995; 80: 3082-3087
        • Safer J.D.
        • Crawford T.M.
        • Holick M.F.
        A role for thyroid hormone in wound healing through keratin gene expression.
        Endocrinology. 2004; 145: 2357-2361
        • Sator P.G.
        • Schmidt J.B.
        • Rabe T.
        • Zouboulis C.C.
        Skin aging and sex hormones in women—clinical perspectives for intervention by hormone replacement therapy.
        Exp Dermatol. 2004; 13: 36-40
        • Phillips T.J.
        • Demircay Z.
        • Sahu M.
        Hormonal effects on skin aging.
        Clin Geriatr Med. 2001; 17: 661-672
        • Schneider J.B.
        • Norman R.A.
        Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly.
        Dermatol Clin. 2004; 22: 23-31
        • Lange M.
        • Thulesen J.
        • Feldt-Rasmussen U.
        • et al.
        Skin morphological changes in growth hormone deficiency and acromegaly.
        Eur J Endocrinol. 2001; 145: 147-153
        • Abramovici A.
        • Josefsberg Z.
        • Mimouni M.
        • et al.
        Histopathological features of the skin in hypopituitarism and Laron-type dwarfism.
        Isr J Med Sci. 1983; 19: 515-519
        • McGee S.
        • Abernethy W.B.
        • Simel D.L.
        The rational clinical examination. Is this patient hypovolemic?.
        JAMA. 1999; 281: 1022-1029
        • Barkan A.
        • Glantz I.
        Calcification of auricular cartilages in patients with hypopituitarism.
        J Clin Endocrinol Metab. 1982; 55: 354-357
        • Slominski A.
        • Wortsman J.
        • Luger T.
        • Paus R.
        • Salomon S.
        Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.
        Physiol Rev. 2000; 80: 979-1020
        • Kauser S.
        • Thody A.J.
        • Schallreuter K.U.
        • et al.
        A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes.
        Endocrinology. 2005; 146: 532-543
        • Thody A.J.
        • Graham A.
        Does alpha-MSH have a role in regulating skin pigmentation in humans?.
        Pigment Cell Res. 1998; 11: 265-274
        • Vaudry H.
        • Chartrel N.
        • Desrues L.
        • et al.
        The pituitary-skin connection in amphibians. Reciprocal regulation of melanotrope cells and dermal melanocytes.
        Ann N Y Acad Sci. 1999; 885: 41-56
        • Vazquez-Martinez R.
        • Peinado J.R.
        • Gonzalez De Aguilar J.L.
        • et al.
        Melanotrope cell plasticity: a key mechanism for the physiological adaptation to background color changes.
        Endocrinology. 2001; 142: 3060-3067
        • Oakes S.R.
        • Haynes K.M.
        • Waters M.J.
        • et al.
        Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts.
        J Clin Endocrinol Metab. 1992; 75: 1368-1373
        • Juul A.
        • Hjortskov N.
        • Jepsen L.T.
        • et al.
        Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients.
        J Clin Endocrinol Metab. 1995; 80: 3335-3340
        • Juul A.
        • Behrenscheer A.
        • Tims T.
        • et al.
        Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise.
        Clin Endocrinol (Oxf). 1993; 38: 237-244
        • Harrison B.J.
        • Kumar S.
        • Read G.F.
        • et al.
        Hidradenitis suppurativa: evidence for an endocrine abnormality.
        Br J Surg. 1985; 72: 1002-1004
        • Matsuoka L.Y.
        • Wortsman J.
        • Gavin J.R.
        • Goldman J.
        Spectrum of endocrine abnormalities associated with acanthosis nigricans.
        Am J Med. 1987; 83: 719-725
        • Lavalle C.
        • Loyo E.
        • Paniagua R.
        • et al.
        Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus.
        J Rheumatol. 1987; 2: 268-272
        • Robertson M.T.
        Prolactin, human nutrition and evolution, and the relation to cystic fibrosis.
        Med Hypotheses. 1989; 29: 87-99
        • De Mello-Coelho V.
        • Savino W.
        • Postel-Vinay M.C.
        • Dardenne M.
        Role of prolactin and growth hormone on thymus physiology.
        Dev Immunol. 1998; 6: 317-322
        • Ogueta S.
        • Munoz J.
        • Obregon E.
        • et al.
        Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow–derived mesenchymal stem cells.
        Mol Cell Endocrinol. 2002; 25: 51-63
        • Taussig L.M.
        • Braunstein G.D.
        Effects of vasopressin on sweat rate and composition in patients with diabetes insipidus and normal controls.
        J Invest Dermatol. 1973; 60: 197-202
        • Shimizu H.
        • Obi T.
        • Miyajima H.
        Anhidrosis: an unusual presentation of diabetes insipidus.
        Neurology. 1997; 49: 1708-1710
        • Ring A.
        • Mork A.C.
        Electrophysiological responses to oxytocin and ATP in monolayers of a human sweat gland cell line.
        Biochem Biophys Res Commun. 1997; 234: 30-34
        • Christianson H.B.
        Cutaneous manifestations of hypothyroidism including purpura and ecchymoses.
        Cutis. 1976; 17: 45-52
        • Levin N.A.
        • Greer K.E.
        Cutaneous manifestations of endocrine disorders.
        Dermatol Nurs. 2001; 13: 185-202
        • Carlson H.E.
        The pituitary gland in systemic disorders.
        in: Melmed S. Pituitary. 2nd ed. Blackwell, Malden2002: 613-627
        • Arafah B.M.
        Medical management of hypopituitarism in patients with pituitary adenomas.
        Pituitary. 2002; 5: 109-117
        • Rhoden E.L.
        • Morgentaler A.
        Medical progress: risks of testosterone-replacement therapy and recommendations for monitoring.
        N Engl J Med. 2004; 350: 482-492
      1. Ezzat S. The pituitary patient resource guide. 3rd ed. Pituitary Network Association, Thousand Oaks, CA2005